Here, it was found that NR4A3 was significantly lower expressed in patients with bladder cancer, whereas JorA could increase NR4A3 expression in bladder cancer T24 cells, suggesting that JorA may exert its tumor suppressor effect through the regulation of NR4A3. The gene discussed is NR4A3; the disease is urinary bladder carcinoma.